PLGA-based nanoparticles: an overview of biomedical applications

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Nanotechnology

Background:

• Poly(lactic-co-glycolic acid) (PLGA) is a leading biodegradable polymer for nanoparticle formulation.
• PLGA offers advantages including biocompatibility, FDA/EMA approval, and adaptability for various drug types.
• Its properties facilitate drug protection, sustained release, and surface modification for enhanced biological interaction.

Purpose of the Study:

• To review the rationale behind selecting PLGA for nanoparticle-based drug delivery systems.
• To explore the specific characteristics of PLGA nanoparticles utilized for targeted delivery.
• To discuss applications in vaccination, cancer, inflammation, and other disease treatments.

Main Methods:

• Literature review of PLGA nanoparticle formulations and applications.
• Analysis of PLGA properties relevant to drug delivery and targeting.
• Examination of case studies in various biomedical fields.

Main Results:

• PLGA nanoparticles are chosen for their biodegradability, biocompatibility, and regulatory approval.
• PLGA enables controlled drug release, protection from degradation, and surface functionalization.
• Targeting capabilities allow for specific organ, tissue, or cell delivery.

Conclusions:

• PLGA is a highly suitable material for developing advanced drug delivery nanoparticles.
• Its tunable properties facilitate targeted therapies and improved treatment outcomes.
• PLGA-based nanoparticles show significant promise across diverse biomedical applications.